Memory and Dementia studies
IDEAL2 Study – Living well and enhancing active life - The IDEAL2 study aimed to provide evidence about living well with dementia, service use and areas of unmet need for people living with dementia. Although the data is still being analysed, they have launched a “Dementia Toolkit” and have a series of publication summaries on their website.
Access the Dementia Toolkit by visiting the Living with Dementia website
Access the key publications by visiting the Ideal Project website
SYMBAD - The SYMBAD trial was a study of mirtazapine for agitation in Dementia. DPT were part of the multi-centre trial to assess the safety, clinical and cost effectiveness of mirtazapine in patients with Alzhiemer’s disease and agitated behaviours. The results of the study have recently been published, finding mirtazapine ineffective at reducing agitation symptoms. Full details available in the Lancet.
AD Genetics - AD Genetics involved researchers analysing the genome of more than 100,000 people with Alzheimer’s disease, then comparing them with over 600,000 healthy individuals to look for difference in genetic makeup. They identified 42 new genes associated with Alzheimer’s disease. Tje link to news article can be found here.
Brains for Dementia - "Brains for Dementia Research now has 3200 people with and without dementia undergoing regular assessments. We continue to be very grateful to all those who have chosen to support dementia research in this way". Access the Alzheimer’s Society page here.
GERAS - Resource utilisation, costs and clinical outcomes in non-institutionalised patients with Alzheimer’s disease: 18-month UK results from the GERAS observational study. You can find the published article here.
MAGD - Efficacy of Memantine for Agitation in Alzheimer’s Dementia: A Randomised Double-Blind Placebo Controlled Trial. You can find the published article here.
Google Calendar as prospective memory aid - Google Calendar: A Memory Aid for People with Prospective Memory Impairment Following Acquired Brain Injury. You can access the published article here.